XML 27 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 8 - Restricted Stock
12 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(
8
)
Restricted Stock
 
On
July 28, 2006,
the Company received shareholder approval for the adoption of the
2006
Employee Equity Compensation Restricted Stock Plan (the
“2006
Employee Plan”) and the
2006
Outside Director Equity Compensation Restricted Stock Plan (the
“2006
Director Plan”). The purpose of the plans was to promote the interests of the Company by securing and retaining both employees and outside directors. The Company had reserved
1.0
million shares of common stock for issuance under the Employee Plan, and
200,000
shares of common stock for issuance under the Director Plan. In
July 2012,
the Company received shareholder approval to ratify the amendment to the Company’s Director Plan passed by the Board of Directors to increase the number of shares available for issuance under the Director Plan from
200,000
to
400,000.
Additionally, the Company received shareholder approval to ratify the amendment passed by the Board of Directors to provide for a
10%
automatic increase every year in the amount of shares available for issuance under both of the plans.
 
In
July 2015,
the Company’s
2015
Outside Director Equity Compensation Restricted Stock Plan (
“2015
Director Plan”) became effective upon the approval of the plan by the Company’s Shareholders. The
2015
Director Plan authorizes
400,000
shares of the Company's common stock available for issuance under the plan, and provides for an automatic increase every year in the amount of shares available for issuance under the plan of
10%
of the shares authorized under the plan. In
July 2016,
the Company’s
2016
Employee Equity Compensation Restricted Stock Plan (
“2016
Employee Plan”) became effective upon the approval of the plan by the Company’s Shareholders. The
2016
Employee Plan authorizes
1,000,000
shares of the Company's Common stock available for issuance under the plan. The value of the restricted stock is determined based on the market value of the stock at the issuance date. The restriction period or forfeiture period is determined by the Company’s Board and is to be
no
less than
1
year and
no
more than
ten
years.
 
The Company had
974,609
restricted common shares issued under the
2006
Employee Plan,
47,350
restricted common shares issued under the
2016
Employee Plan,
272,000
restricted common shares issued under the
2006
Director Plan, and
60,000
restricted common shares issued under the
2015
Director Plan at
March 31, 2018.
All shares were issued subject to a restriction or forfeiture period which will lapse ratably on the first, second, and
third
anniversaries of the date of grant, and the fair value of which is being amortized over the
three
-year restriction period. For the fiscal years ended
March 31, 2018,
2017,
and
2016,
the Company recognized compensation expense related to the Employee and Director Plans of
$2.6
million,
$1.9
million, and
$1.6
million, respectively.
 
A summary of the Company’s non-vested restricted stock at
March 31, 2018
is as follows:
 
   
Employee Plan
Number of Shares
(In thousands)
   
Director Plan
Number of Shares
(In thousands)
   
Both Plans
Number of Shares
(In thousands)
 
                         
Non-vested restricted stock outstanding at March 31, 2017
   
172
     
60
     
232
 
                         
Restricted stock granted
   
49
     
30
     
79
 
                         
Restricted stock vested
   
(84
)    
(30
)    
(114
)
                         
Restricted stock forfeited or expired
   
(4
)    
-
     
(4
)
                         
Non-vested restricted stock outstanding at March 31, 2018
   
133
     
60
     
193
 
 
At
March 31, 2018
and
2017,
there were
192,968
and
232,253,
non-vested restricted stock shares outstanding, respectively. During the fiscal years ended
March 31, 2018
and
2017,
the Company issued, net of forfeitures,
75,081
and
78,582
restricted shares, respectively. At
March 31, 2018
and
2017,
there were
$4.4
million and
$3.3
million of unrecognized compensation cost related to the non-vested restricted stock awards, respectively, which is expected to be recognized over the remaining weighted average vesting period of
1.5
years and
1.8
years for fiscal
2018
and
2017,
respectively.